SCHEMBL644884

SCHEMBL644884

CC(C)NCCOc1ccccc1CN(C)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.47
HSP90AB1 P08238 1/20 0.33
HTR1B P28222 1/20 0.30
ADRA1D P25100 2/20 0.30
ADRA1A P35348 2/20 0.30
ADRA1B P35368 2/20 0.30
ADRB2 P07550 1/20 0.30
ADRB1 P08588 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
DRD2 P14416 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30
HTR2A P28223 1/20 0.30
HTR7 P34969 1/20 0.30
OPRM1 P35372 1/20 0.30
DRD3 P35462 1/20 0.30
HTR2B P41595 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647283 0.93 HSP90AA1 (0.39) HSP90AA1HSP90AB1HTR1BADRA1DADRA1A
SCHEMBL10179986 0.92 HSP90AA1 (0.47) HSP90AA1HSP90AB1HTR1BADRA1DADRA1A
SCHEMBL646871 0.92 HSP90AA1 (0.46) HSP90AA1HSP90AB1ADRA1DADRA1AADRA1B
SCHEMBL645309 0.89 HSP90AA1 (0.47) HSP90AA1HSP90AB1
SCHEMBL646597 0.89 HSP90AA1 (0.47) HSP90AA1HSP90AB1
SCHEMBL10180014 0.89 HSP90AA1 (0.47) HSP90AA1HSP90AB1DRD2HTR7
SCHEMBL646699 0.87 HSP90AA1 (0.49) HSP90AA1HSP90AB1
SCHEMBL646252 0.87 HSP90AA1 (0.45) HSP90AA1HSP90AB1
SCHEMBL646532 0.86 HSP90AA1 (0.49) HSP90AA1HSP90AB1
SCHEMBL10170529 0.84 HSP90AA1 (0.47) HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885HSP90AB1 1/4885HTR1B 1790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.